Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.14 - $19.14 $248,296 - $313,896
16,400 New
16,400 $252,000
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $245,502 - $425,868
13,800 New
13,800 $255,000
Q3 2023

Nov 15, 2023

BUY
$20.84 - $33.47 $548,092 - $880,261
26,300 New
26,300 $548,000
Q2 2021

Aug 06, 2021

SELL
$19.4 - $27.42 $1.23 Million - $1.73 Million
-63,200 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$25.02 - $54.99 $1.58 Million - $3.48 Million
63,200 New
63,200 $1.63 Million
Q4 2020

Feb 12, 2021

SELL
$41.04 - $56.79 $615,600 - $851,850
-15,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$36.42 - $57.0 $244,014 - $381,900
6,700 Added 80.72%
15,000 $606,000
Q2 2020

Aug 13, 2020

BUY
$39.26 - $52.73 $325,858 - $437,659
8,300 New
8,300 $400,000
Q1 2020

May 11, 2020

SELL
$31.65 - $46.87 $1.26 Million - $1.87 Million
-39,800 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$36.21 - $51.4 $1.44 Million - $2.05 Million
39,800 New
39,800 $1.72 Million
Q2 2019

Aug 20, 2019

SELL
$23.32 - $28.12 $755,568 - $911,088
-32,400 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$16.17 - $27.38 $341,187 - $577,718
-21,100 Reduced 39.44%
32,400 $870,000
Q4 2018

Feb 14, 2019

BUY
$14.32 - $22.92 $103,104 - $165,024
7,200 Added 15.55%
53,500 $837,000
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $603,289 - $1.01 Million
46,300 New
46,300 $961,000
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $762,256 - $1.11 Million
-28,400 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$29.49 - $38.37 $837,516 - $1.09 Million
28,400
28,400 $1.07 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.